Abstract
A woman with sickle cell disease and multiple historical red cell antibodies received several red cell units in preparation for surgery. The laboratory did not select M-negative units for transfusion, assuming that the anti-M, one of the historical antibodies, is a cold-reacting antibody. A delayed hemolytic reaction due to an anti-M ensued. Causes of alloimmunization to red cell antigens, common in sickle cell disease, are discussed; characteristics of delayed hemolytic transfusion reactions in sickle cell disease are outlined. In its most severe form, hemolysis affects autologous red cells, a phenomenon called “sickle cell hemolytic transfusion reaction syndrome,” or “hyperhemolysis.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Howard J, Malfroy M, Llewellyn C, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet. 2013;381:930–8.
Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of aggressive and conservative transfusion regimens in the preoperative management of sickle cell disease. N Engl J Med. 1995;333:206–13.
Harm SK, Yazer MH, Monis GF, et al. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol. 2014;141:256–61.
Pirenne F, Yazdanabkhsh K. How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions. Blood. 2018;131:2773–81.
Gardner K, Hoppe C, Mijovic A, Thein SL. How we treat delayed hemolytic transfusion reaction in patients with sickle cell disease. Br J Haematol. 2015;170:745–56.
Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion. 1997;37:357–61.
Petz LD, Calhoun L, Schulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37:382–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mijovic, A. (2023). Dial M for HeMolysis. In: Mijovic, A. (eds) Transfusion Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-31462-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-31462-9_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31461-2
Online ISBN: 978-3-031-31462-9
eBook Packages: MedicineMedicine (R0)